Bulay, Wilfreda C.

HRN: 27-90-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2025
CEFTRIAXONE 1G (VIAL)
10/04/2025
10/10/2025
IV
2 Grams
Od
Cap Mr
Waiting Final Action 
10/04/2025
AZITHROMYCIN 500MG TABLET (TAB)
10/04/2025
10/08/2025
PO
500 Mg
Od
Pneumonia
Waiting Final Action 
10/04/2025
RIFAXIMIN 200MG (TAB)
10/04/2025
10/10/2025
PO
200
TID
Liver Cirrhosis
Waiting Final Action 
10/07/2025
RIFAXIMIN 200MG (TAB)
10/07/2025
10/14/2025
ORAL
200mg
Tid
Hepatitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: